You have changed your country from  to  . Please be aware that this will change the currency in the purchasing process.

Anti-SREBP1 antibody [2A4] (ab3259)

CodeSizePriceAbpointsAvailability
    
 
  • -

  •   
  •   
  •   
  •  

  •  
  •  
  •  

  •  
Updating...

Reassurance, Refunds & Replacements

If your product does not perform as described on this datasheet, we will refund or replace your product...

Read our guarantee »

Publishing research using ab3259? Please let us know so that we can cite the reference in this datasheet

Show applications key

ab3259 has been referenced in 5 publications.

  1. Peng Z et al. Adenosine signaling contributes to ethanol-induced fatty liver in mice. J Clin Invest 119:582-94 (2009). WB; Mouse. PubMed: 19221436
  2. López-Soldado I et al. Suppression of VLDL secretion by cultured hepatocytes incubated with chylomicron remnants enriched in n-3 polyunsaturated fatty acids is regulated by hepatic nuclear factor-4alpha. Biochim Biophys Acta 1791:1181-9 (2009). WB; Rat. PubMed: 19699314
  3. Wang Y et al. Elevated hepatic fatty acid elongase-5 (elovl-5) activity affects multiple pathways controlling hepatic lipid and carbohydrate composition. J Lipid Res : (2008). WB; Rat. PubMed: 18376007
  4. Schmidt LJ et al. Inhibition of fatty acid synthase activity in prostate cancer cells by dutasteride. Prostate 67:1111-20 (2007). PubMed: 17477363
  5. Schmidt RJ et al. A 15-ketosterol is a liver X receptor ligand that suppresses sterol-responsive element binding protein-2 activity. J Lipid Res 47:1037-44 (2006). PubMed: 16415294

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"